REPROCELL is thrilled to celebrate a groundbreaking milestone by our partner Gameto, who recently announced the birth of the first baby born using Fertilo, a proprietary in vitro oocyte maturation technology. This major medical advancement marks a pivotal breakthrough in redefining women’s healthcare, supported by our StemRNA™ Clinical induced Pluripotent Stem Cells (iPSCs).
Qkine announces partnership with REPROCELL: Global distributorship for high quality bioactive proteins for stem cell culture Cambridge, UK and Yokohama, Japan – Qkine Ltd., a specialist bioactive protein manufacturer with its core technology developed at the University of Cambridge, and REPROCELL Inc., Japan’s first and leading induced pluripotent stem cell (iPSC) company, have partnered to globally…
Hyderabad, India – 22nd July 2024 – Bioserve India is excited to announce the launch of its advanced stem cell products in India. These new products from REPROCELL aims to support innovation in scientific research and drug development, supporting advancements in regenerative medicine and therapeutic discovery in Indian Market. The stem cell market is a rapidly growing industry that encompasses a wide range of services and products. Within the stem cell market, numerous industries are engaged in critical activities such as research and development manufacturing, and distribution of stem cell therapy products.
REPROCELL is pleased to announce the offering of Master Cell Bank (MCB) manufacturing service for generation of Human Induced Pluripotent Cells (hiPSC) and Human Mesenchymal Stem Cells (hMSC) for human therapeutic applications.
Hyderabad, India and Doha, Qatar – May 6, 2024 – Bioserve Biotechnologies (India) Private Limited, a leader in molecular biology products, is excited to announce a new distributorship agreement with RISVI Trading W.L.L., a renowned trading company based in Doha, Qatar. This strategic partnership will enable Bioserve to expand its distribution network for molecular biology products, including DNA oligonucleotide synthesis in Qatar.
Hyderabad, India, 27th September 2023: Bioserve Biotechnologies (India) Private Limited, a leader in molecular biology products, is teaming up with BioMavericks Ltd., a UK-based company. This partnership will allow Bioserve to extend its molecular biology product distribution, including DNA oligonucleotide synthesis across the United Kingdom.
Yokohama Japan, 23 November 2022: REPROCELL Inc. decided to invest in Histocell S.L. to strengthen its clinical induced pluripotent stem cell (iPSC) service offerings.